Effect of Spironolactone in Treating Chronic Non-resolutive Central Serous Chorioretinitis

NCT01552044 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER_GOV

Sponsor class

Conditions

Central Serous Chorioretinitis

Interventions

DRUG: Spironolactone
DRUG: Placebo

Sponsor

Institut National de la Santé Et de la Recherche Médicale, France